• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学亚型对肾癌患者生存概率影响的综合分析:超弹性生存分析

A Comprehensive Analysis of the Effect of Histological Subtypes on the Survival Probability of Kidney Carcinoma Patients: A Hypertabastic Survival Analysis.

作者信息

Tabatabai Mohammad, Bailey Stephanie, Matthews-Juarez Patricia, Tabatabai Habib, Bahri Nader, Cooper Lyle, Wilus Derek, Singh Karan, Juarez Paul

机构信息

Meharry Medical College, Nashville, USA.

University of Wisconsin Milwaukee, Milwaukee, USA.

出版信息

J Ren Cancer. 2020;3(1):20-33. doi: 10.36959/896/604. Epub 2020 Dec 28.

DOI:10.36959/896/604
PMID:39450304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11500793/
Abstract

The purpose of this study is two-fold. First, to find out whether the histological subtypes can serve as an independent prognostic factor for kidney carcinoma; and second, whether it's role can be maintained when we control for confounders. Using National Cancer Institute data from 1975-2016, we have modeled the impact of histological subtypes on the survival probability of kidney carcinoma patients. A total of 134,150 individuals were examined from the Surveillance, Epidemiology, and End Results program (SEER) [1]. The study variables are age, race/ethnicity, sex, tumor grade, type of surgery, geographical location of patient and stage of disease. We have applied the Hypertabastic proportional hazards survival model [2-6] to analyze the survival time of patients diagnosed with kidney carcinoma in order to explore the effect of histological subtypes on their survival probability. In particular, our intention was to assess the relationship between the histological subtypes and tumor stage, grade, and type of surgery. Our results indicated that histology plays an important role both when used as the sole predictor in the survival model ( < 0.001), as well as when controlling for confounding variables ( < 0.001).

摘要

本研究的目的有两个。其一,探究组织学亚型是否可作为肾癌的独立预后因素;其二,在控制混杂因素时其作用是否依然存在。利用美国国立癌症研究所1975年至2016年的数据,我们对组织学亚型对肾癌患者生存概率的影响进行了建模。从监测、流行病学和最终结果项目(SEER)中总共检查了134,150个人[1]。研究变量包括年龄、种族/民族、性别、肿瘤分级、手术类型、患者地理位置和疾病分期。我们应用超弹性比例风险生存模型[2 - 6]来分析被诊断为肾癌患者的生存时间,以探究组织学亚型对其生存概率的影响。特别是,我们旨在评估组织学亚型与肿瘤分期、分级及手术类型之间的关系。我们的结果表明,组织学在作为生存模型中的唯一预测因素时(<0.001)以及在控制混杂变量时(<0.001)均发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/2665d1800120/nihms-2025945-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/4a39dd5e69b4/nihms-2025945-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/01c55377eaee/nihms-2025945-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/9a42281b0fb4/nihms-2025945-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/655230850b1d/nihms-2025945-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/27d406e24bcd/nihms-2025945-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/3c8251bd931f/nihms-2025945-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/bcbcc5fbe8f5/nihms-2025945-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/bd3598b9a6cf/nihms-2025945-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/2665d1800120/nihms-2025945-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/4a39dd5e69b4/nihms-2025945-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/01c55377eaee/nihms-2025945-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/9a42281b0fb4/nihms-2025945-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/655230850b1d/nihms-2025945-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/27d406e24bcd/nihms-2025945-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/3c8251bd931f/nihms-2025945-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/bcbcc5fbe8f5/nihms-2025945-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/bd3598b9a6cf/nihms-2025945-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/11500793/2665d1800120/nihms-2025945-f0009.jpg

相似文献

1
A Comprehensive Analysis of the Effect of Histological Subtypes on the Survival Probability of Kidney Carcinoma Patients: A Hypertabastic Survival Analysis.组织学亚型对肾癌患者生存概率影响的综合分析:超弹性生存分析
J Ren Cancer. 2020;3(1):20-33. doi: 10.36959/896/604. Epub 2020 Dec 28.
2
The role of histological subtypes in the survival of patients diagnosed with cutaneous or mucosal melanoma in the United States of America.美国皮肤或黏膜黑色素瘤患者的组织学亚型与生存的关系。
PLoS One. 2023 Jun 5;18(6):e0286538. doi: 10.1371/journal.pone.0286538. eCollection 2023.
3
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: .按年龄、性别、种族、分期、分级、队列入组时间、疾病持续时间及选定的ICD-O-3肿瘤学表型对胃癌进行的20年生存和死亡率比较:
J Insur Med. 2019;48(1):5-23. doi: 10.17849/insm-48-1-1-19.1. Epub 2019 Oct 14.
4
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.国际妇产科联盟(FIGO)分期、组织学类型、组织学分级、年龄和种族作为女性生殖系统癌症生存预后因素的分析:1973 - 1987年美国监测、流行病学和最终结果(SEER)项目中子宫内膜癌、宫颈癌、卵巢癌、外阴癌及阴道癌病例分析
Semin Surg Oncol. 1994 Jan-Feb;10(1):31-46. doi: 10.1002/ssu.2980100107.
5
Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).非霍奇金淋巴瘤-淋巴结内和淋巴结外:20 年死亡率、生存率和生物学行为比较分析,按年龄、性别、种族、分期、细胞形态/组织学、队列入组时间-时期和疾病持续时间分层:对 1975-2016 年诊断年的 384651 例非霍奇金淋巴瘤(NHL)总病例(包括 261144 例淋巴结内和 123507 例淋巴结外病例)进行的系统评价:(SEER*Stat 8.3.6)。
J Insur Med. 2023 Jul 1;50(1):1-35. doi: 10.17849/insm-50-1-1-35.1.
6
The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer.组织学亚型对IV期上皮性卵巢癌预后的影响
Front Oncol. 2018 Dec 4;8:577. doi: 10.3389/fonc.2018.00577. eCollection 2018.
7
Analysis of Prognostic Factors and Construction of Prognostic Models for Invasive Micropapillary Carcinoma of the Breast.浸润性微乳头状乳腺癌预后因素分析及预后模型的构建。
Comput Math Methods Med. 2022 Oct 26;2022:1072218. doi: 10.1155/2022/1072218. eCollection 2022.
8
Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.头颈部小细胞和鳞状细胞癌:基于监测、流行病学和最终结果(SEER)数据比较发病率和生存趋势。
Oncologist. 2019 Dec;24(12):1562-1569. doi: 10.1634/theoncologist.2018-0054. Epub 2019 Aug 7.
9
Clinical and multiple gene expression variables in survival analysis of breast cancer: analysis with the hypertabastic survival model.乳腺癌生存分析中的临床和多基因表达变量:使用超余生存模型的分析。
BMC Med Genomics. 2012 Dec 14;5:63. doi: 10.1186/1755-8794-5-63.
10
Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.基于人群的乳腺癌患者队列中的激素受体状态与生存情况
Cancer. 2005 Jun 1;103(11):2241-51. doi: 10.1002/cncr.21030.

本文引用的文献

1
Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma.肾透明细胞癌中沉默调节蛋白的综合分析及其预后意义
Front Oncol. 2020 Feb 25;10:218. doi: 10.3389/fonc.2020.00218. eCollection 2020.
2
Pan-Renal Cell Carcinoma classification and survival prediction from histopathology images using deep learning.基于深度学习的肾周细胞癌组织病理学图像分类与生存预测。
Sci Rep. 2019 Jul 19;9(1):10509. doi: 10.1038/s41598-019-46718-3.
3
Tumor laterality in renal cancer as a predictor of survival in large patient cohorts: A STROBE compliant study.
肾癌的肿瘤侧别作为大型患者队列生存的预测因素:一项符合STROBE标准的研究
Medicine (Baltimore). 2019 Apr;98(17):e15346. doi: 10.1097/MD.0000000000015346.
4
Chromophobe renal cell carcinoma or oncocytoma: a manner of challenge in frozen section diagnosis.嫌色性肾细胞癌或嗜酸细胞瘤:冰冻切片诊断中的一项挑战
Biomedicine (Taipei). 2019 Mar;9(1):6. doi: 10.1051/bmdcn/2019090106. Epub 2019 Feb 22.
5
Gastric cancer trends in Estonia 1995-2014 by age, subsite, morphology and stage.爱沙尼亚 1995-2014 年胃癌的年龄、部位、形态和分期趋势。
Acta Oncol. 2019 Mar;58(3):283-289. doi: 10.1080/0284186X.2018.1546058. Epub 2019 Jan 11.
6
Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy.转移性肾细胞癌患者接受一线靶向治疗时可变的条件生存率及其相关预后因素。
J Urol. 2018 Nov;200(5):989-995. doi: 10.1016/j.juro.2018.06.030. Epub 2018 Jun 22.
7
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.在非转移性疾病中,乳头状肾细胞癌与透明细胞肾细胞癌的预后差异显著。
PLoS One. 2017 Sep 21;12(9):e0184173. doi: 10.1371/journal.pone.0184173. eCollection 2017.
8
Renal cell carcinoma.肾细胞癌。
Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9.
9
Comparison of hypertabastic survival model with other unimodal hazard rate functions using a goodness-of-fit test.使用拟合优度检验比较超弹性生存模型与其他单峰风险率函数。
Stat Med. 2017 May 30;36(12):1936-1945. doi: 10.1002/sim.7244. Epub 2017 Feb 7.
10
How generalizable are the SEER registries to the cancer populations of the USA?美国监测、流行病学和最终结果(SEER)登记处的数据对美国癌症人群的普遍适用性如何?
Cancer Causes Control. 2016 Sep;27(9):1117-26. doi: 10.1007/s10552-016-0790-x. Epub 2016 Jul 21.